André Alvares Marques Vale Selected Research

Ruthenium

2/2020

Ruthenium (II) complexes with N, O-chelating proline and threonine ligands cause selective cytotoxicity by the induction of genomic instability, cell cycle arrest and apoptosis in breast and prostate tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

André Alvares Marques Vale Research Topics

Disease

3	Neoplasms (Cancer) 05/2022 - 01/2019
1	Genomic Instability 02/2020
1	Osteoarthritis 09/2019
1	Pain (Aches) 09/2019
1	Knee Osteoarthritis 09/2019
1	Edema (Dropsy) 09/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Inflammation (Inflammations) 01/2019

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 09/2019 - 01/2019
1	FlavonoidsIBA 05/2022
1	lissamine rhodamine B (sulforhodamine B)IBA 05/2022
1	Proline (L-Proline)FDA Link 02/2020
1	LigandsIBA 02/2020
1	RutheniumIBA 02/2020
1	Threonine (L-Threonine)FDA Link 02/2020
1	Complex MixturesIBA 09/2019
1	SodiumIBA 09/2019
1	Therapeutic UsesIBA 09/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2019
1	HSP27 Heat-Shock ProteinsIBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 05/2022
1	Intra-Articular Injections 09/2019